BIND Screener Can ID Brain-Related Comorbidities in Duchenne Muscular Dystrophy
FDA Approves Generic Emflaza Oral Suspension for Duchenne Muscular Dystrophy
Vamorolone Effective, Safe for Boys With Duchenne Muscular Dystrophy
Home Monitoring of Lung Function Feasible in Teens With Duchenne
About Half Have Meaningful Drop in Long COVID Symptoms by 36 Months
Genetic Screening Can ID Hemoglobinopathy Prevalence
Few Meet Major Clinical Response Criteria After Treatment Escalation for Lupus
Nonpharmacologic Therapy Cuts Opioid Use Disorder Risk With Low Back Pain
BIND Screener Can ID Brain-Related Comorbidities in Duchenne Muscular Dystrophy 
FDA Approves Generic Emflaza Oral Suspension for Duchenne Muscular Dystrophy 
Vamorolone Effective, Safe for Boys With Duchenne Muscular Dystrophy 
Home Monitoring of Lung Function Feasible in Teens With Duchenne 
About Half Have Meaningful Drop in Long COVID Symptoms by 36 Months 
Genetic Screening Can ID Hemoglobinopathy Prevalence 
Few Meet Major Clinical Response Criteria After Treatment Escalation for Lupus 
Nonpharmacologic Therapy Cuts Opioid Use Disorder Risk With Low Back Pain 
